Targeted Therapies and Companion Diagnostic Tests. From development to “market access” Targeted Therapies and Companion Diagnostic Tests. From Development to “Market Access”.
January 12 & 14, 2021 Overview: Understand the definitions and regulatory framework governing these products. Impact of new European DM regulations and DMDIV. How to proceed with the analytical validation. How to demonstrate clinical validity and prove clinical utility. What development strategy to adopt?. And much more. Click here for more details.
